A detailed history of Hantz Financial Services, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 358 shares of OGN stock, worth $5,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
358
Previous 328 9.15%
Holding current value
$5,355
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.65 - $23.03 $559 - $690
30 Added 9.15%
358 $7,000
Q2 2024

Jul 30, 2024

BUY
$17.45 - $21.96 $5,723 - $7,202
328 New
328 $7,000
Q1 2024

Aug 06, 2024

BUY
$13.78 - $18.8 $3,500 - $4,775
254 Added 76.74%
585 $11,000
Q4 2023

Aug 06, 2024

SELL
$10.95 - $17.32 $1,149 - $1,818
-105 Reduced 24.08%
331 $5,000
Q3 2023

Aug 06, 2024

SELL
$16.59 - $23.77 $16 - $23
-1 Reduced 0.23%
436 $8,000
Q2 2023

Aug 06, 2024

SELL
$19.27 - $24.63 $96 - $123
-5 Reduced 1.13%
437 $9,000
Q1 2023

Aug 06, 2024

SELL
$21.42 - $32.08 $4,026 - $6,031
-188 Reduced 29.84%
442 $10,000
Q4 2022

Aug 06, 2024

SELL
$23.31 - $28.61 $139 - $171
-6 Reduced 0.94%
630 $18,000
Q3 2022

Aug 06, 2024

SELL
$23.4 - $34.25 $234 - $342
-10 Reduced 1.55%
636 $15,000
Q2 2022

Aug 06, 2024

SELL
$31.66 - $38.9 $474 - $583
-15 Reduced 2.27%
646 $22,000
Q1 2022

Aug 06, 2024

BUY
$30.45 - $39.36 $182 - $236
6 Added 0.92%
661 $23,000
Q4 2021

Aug 06, 2024

SELL
$28.67 - $37.13 $602 - $779
-21 Reduced 3.11%
655 $20,000
Q3 2021

Aug 06, 2024

SELL
$28.63 - $35.64 $1,173 - $1,461
-41 Reduced 5.72%
676 $22,000
Q2 2021

Aug 06, 2024

BUY
$28.45 - $38.0 $11,067 - $14,782
389 Added 118.6%
717 $22,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.